Desoximetasone clinical trials
How each study uses Desoximetasone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 28 Feb 1977 · TOPICORT · NDA 017856 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 3 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 1
Taro Pharmaceuticals USA (5) · Siriraj Hospital (1)
Related medicines
As reviewed, each with the page that says it.
- One of Corticosteroids source
Studies
Open first, then newest update. How each study uses Desoximetasone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque PsoriasisCompletedPhase 4Taro Pharmaceuticals USANCT02340169Written as Topicort® (desoximetasone) Topical Spray, 0.25%How we know
- Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque PsoriasisCompletedPhase 3Taro Pharmaceuticals USANCT01206387Written as Desoximetasone Spray 0.25%How we know
- Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp PsoriasisStatus unknownPhase 3Siriraj HospitalNCT02749656Written as 0.25% Desoximetasone cream (Topoxy®)How we know
- Desoximetasone Spray 0.05%, 0.25%; Dose Ranging StudyCompletedPhase 2Taro Pharmaceuticals USANCT01018134Written as Desoximetasone 0.05% once dailyHow we know
- Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque PsoriasisCompletedPhase 3Taro Pharmaceuticals USANCT01206660Written as Desoximetasone Spray 0.25%How we know
- Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis StudyCompletedPhase 2Taro Pharmaceuticals USANCT01043393Written as Desoximetasone 0.25% sprayHow we know
Given beside what is tested · 1 — Desoximetasone is usual care or a partner of the new treatment
Codes
What other systems call Desoximetasone · ClinicalTrials.gg INT007320
- MeSH (NLM) D003899DesoximetasoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4E07GXB7AUDESOXIMETASONEConfirmed FDA, NLM, Wikidata
- RxNorm 3255Confirmed FDA, Wikidata
- Wikidata Q385370desoximetasoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47477DesoximetasoneOne source FDA
- DrugBank DB00547One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003899 | Desoximetasone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4E07GXB7AU | DESOXIMETASONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3255 | — | Confirmed FDA, Wikidata |
| Wikidata | Q385370 | desoximetasone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47477 | Desoximetasone | One source FDA |
| DrugBank | DB00547 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.